FARICIMAB
faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL vial
FARICIMAB (14737P)
14737P
Body System:
Manner of administration:Injection
Restriction
Indication: Branch retinal vein occlusion with macular oedema
Treatment phase: Initial treatment
Restriction
Indication: Central retinal vein occlusion with macular oedema
Treatment phase: Initial treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 2 | DPMQ: $934.41 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||